Boehringer Ingelheim is a family-owned company that is also a subsidiary of the larger organization, C.H. Boehringer Sohn AG & Ko. KG. It was started in 1885 in the German town of Ingelheim am Rhein by Albert Boehringer, and it has remained there ever since. The company’s 145 branches are currently employing 42,000 people. The principle tasks of this company are the research and development and manufacturing and marketing of medications for human as well as animal consumption. Recently, the company has been the subject of numerous lawsuits over internal bleeding side effects caused by their drug Pradaxa.
Boehringer Ingelheim is in the top 20 of all pharmaceutical companies currently working in the industry in the world.
Boehringer Ingelheim’s Pharmaceutical Products
The company’s 20 manufacturing plants create medications for humans and animals in several locations throughout the world. Some of their well-known drugs are Aggrenox, Bisolvon, Flomax, Mirapex, Pradaxa, Viramune and Zantac.
For over 20 years, Boehringer Ingelheim has been running a pharma chemicals department that concentrates its attention on monomers and biodegradable polymers.
The Workplaces of Boehringer Ingelheim
The main headquarters are located in Ingelheim am Rhein that is near the city of Frankfurt in Germany. It also has 145 subordinate companies around the world. Europe, North America and Asia supply most of the locations for these subsidiaries. Boehringer Ingelheim has the distinction of being Vienna, Austria’s, Research Institute of Molecular Pathology’s main supporter.
The 2008 employee breakdown for Boehringer Ingelheim’s 41,300 workers shows that 30 percent produce the medicines, 39 percent were in the sales and marketing department while research and development contained 17 percent of the population.
Boehringer Ingelheim is a very good place to work according to Science, Germany’s Capital, Careers & the disABLED Magazine, Workforce Diversity Magazine and the United Kingdom’s Sunday Times.
Boehringer Ingelheim’s Key Events
• Albert Boehringer purchased a tartar factory in Ingelheim am Rhein in 1885
• Albert Boehringer began to manufacture tartaric acid in his new tartar factory in 1886
• C.H. Boehringer Sohn began to manufacture lactic acid and became one of the first to do so in 1895
• Albert Boehringer’s cousin, Heinrich Wieland, future winner of the Nobel Prize, developed a research department for the company in 1917
• Boehringer Ingelheim purchased the research company, Dr. Karl Thomae, in 1928
• Boehringer steps into the veterinary field after purchasing Pfizer’s veterinary program in 1955
• Boehringer came to the United States by establishing a research center in 1971
• Boehringer celebrates 125 years in business in 2010
Pradaxa Internal Bleeding Side Effects Lawsuits: TOOK PRADAXA AND SUFFERED FROM INTERNAL BLEEDING?
If you have taken Pradaxa and suffered from internal bleeding, you may be entitled to collect significant financial compensation by participating in the Pradaxa lawsuits. To find out if you have a case, contact our expert Pradaxia side effect lawyers for a free no obligation consultation by completing the form on this page or calling 1-800-905-2751.